Back to Search Start Over

Epigenetic inhibitors and their role in cancer therapy.

Authors :
Abdelaziz N
Therachiyil L
Sadida HQ
Ali AM
Khan OS
Singh M
Khan AQ
Akil ASA
Bhat AA
Uddin S
Source :
International review of cell and molecular biology [Int Rev Cell Mol Biol] 2023; Vol. 380, pp. 211-251. Date of Electronic Publication: 2023 Aug 01.
Publication Year :
2023

Abstract

Epigenetic modifications to DNA are crucial for normal cellular and biological functioning. DNA methylation, histone modifications, and chromatin remodeling are the most common epigenetic mechanisms. These changes are heritable but still reversible. The aberrant epigenetic alterations, such as DNA methylation, histone modification, and non-coding RNA (ncRNA)-mediated gene regulation, play an essential role in developing various human diseases, including cancer. Recent studies show that synthetic and dietary epigenetic inhibitors attenuate the abnormal epigenetic modifications in cancer cells and therefore have strong potential for cancer treatment. In this chapter, we have highlighted various types of epigenetic modifications, their mechanism, and as drug targets for epigenetic therapy.<br /> (Copyright © 2023. Published by Elsevier Inc.)

Details

Language :
English
ISSN :
1937-6448
Volume :
380
Database :
MEDLINE
Journal :
International review of cell and molecular biology
Publication Type :
Academic Journal
Accession number :
37657859
Full Text :
https://doi.org/10.1016/bs.ircmb.2023.04.005